Joshua Ryan Clayton

Person

Cicero, IN, US

People

Patents Grantslast 30 patents

Information Patent Grant
Glucocorticoid receptor agonists
- Patent number 11,787,834
- Issue date Oct 17, 2023
- Eli Lilly and Company
- Adel Ahmed Rashad Ahmed
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrazolylaminobenzimidazole derivatives as JAK inhibitors
- Patent number 10,344,018
- Issue date Jul 9, 2019
- Eli Lilly and Company
- Jolie Anne Bastian
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pyrazolylaminobenzimidazole derivatives as JAK inhibitors
- Patent number 10,323,019
- Issue date Jun 18, 2019
- Eli Lilly and Company
- Jolie Anne Bastian
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
JAK1 inhibitors
- Patent number 9,556,153
- Issue date Jan 31, 2017
- Eli Lilly and Company
- Joshua Ryan Clayton
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibitor of JAK1 and JAK2
- Patent number 9,062,050
- Issue date Jun 23, 2015
- Eli Lilly and Company
- Timothy Paul Burkholder
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
AKT inhibitors
- Patent number 8,436,002
- Issue date May 7, 2013
- Eli Lilly and Company
- Douglas Wade Beight
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Purine derivatives as kinase inhibitors
- Patent number 8,058,425
- Issue date Nov 15, 2011
- Eli Lilly and Company
- Thomas Albert Engler
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Amino pyrazole compound
- Patent number 7,897,600
- Issue date Mar 1, 2011
- Eli Lilly and Company
- Timothy Paul Burkholder
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Imidazo[1,2-A]pyridine compounds as VEGF-R2 inhibitors
- Patent number 7,666,879
- Issue date Feb 23, 2010
- Eli Lilly and Company
- David Anthony Barda
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrrole-2, 5dione derivatives and their used as GSK-3 inhibitors
- Patent number 7,405,305
- Issue date Jul 29, 2008
- Eli Lilly and Company
- Pamela Ann Albaugh
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
HUMAN INTERLEUKIN-4 RECEPTOR ALPHA ANTIBODY GLUCOCORTICOID CONJUGATES
- Publication number 20240100176
- Publication date Mar 28, 2024
- Eli Lilly and Company
- Shane Krummen Atwell
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HUMAN TUMOR NECROSIS FACTOR ALPHA ANTIBODY GLUCOCORTICOID CONJUGATES
- Publication number 20240082414
- Publication date Mar 14, 2024
- Eli Lilly and Company
- Grace Chao
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
GLUCOCORTICOID RECEPTOR AGONISTS
- Publication number 20240018182
- Publication date Jan 18, 2024
- Eli Lilly and Company
- Adel Ahmed Rashad AHMED
- C07 - ORGANIC CHEMISTRY
Information Patent Application
GLUCOCORTICOID RECEPTOR AGONISTS
- Publication number 20220324904
- Publication date Oct 13, 2022
- Eli Lilly and Company
- Adel Ahmed Rashad AHMED
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRAZOLYLAMINOBENZIMIDAZOLE DERIVATIVES AS JAK INHIBITORS
- Publication number 20190177300
- Publication date Jun 13, 2019
- Eli Lilly and Company
- Jolie Anne Bastian
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRAZOLYLAMINOBENZIMIDAZOLE DERIVATIVES AS JAK INHIBITORS
- Publication number 20180325873
- Publication date Nov 15, 2018
- Eli Lilly and Company
- Jolie Anne Bastian
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
JAK1 Inhibitors
- Publication number 20170037034
- Publication date Feb 9, 2017
- Eli Lilly and Company
- Joshua Ryan Clayton
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITOR OF JAK1 AND JAK2
- Publication number 20150133490
- Publication date May 14, 2015
- Eli Lilly and Company
- Timothy Paul Burkholder
- C07 - ORGANIC CHEMISTRY
Information Patent Application
AKT INHIBITORS
- Publication number 20120149684
- Publication date Jun 14, 2012
- Eli Lilly and Company
- Douglas Wade Beight
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PURINE DERIVATIVES AS KINASE INHIBITORS
- Publication number 20110294792
- Publication date Dec 1, 2011
- Eli Lilly and Company
- Thomas Albert Engler
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PURINE DERIVATIVES AS KINASE INHIBITORS
- Publication number 20110207721
- Publication date Aug 25, 2011
- Eli Lilly and Company
- Thomas Albert Engler
- C07 - ORGANIC CHEMISTRY
Information Patent Application
AMINO PYRAZOLE COMPOUND
- Publication number 20100286139
- Publication date Nov 11, 2010
- Eli Lilly and Company
- Timothy Paul Burkholder
- C07 - ORGANIC CHEMISTRY
Information Patent Application
AMINO PYRAZOLE COMPOUND
- Publication number 20100152181
- Publication date Jun 17, 2010
- Eli Lilly and Company
- Timothy Paul Burkholder
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IMIDAZO[1,2-A]PYRIDINE COMPOUNDS AS VEGF-R2 INHIBITORS
- Publication number 20090227622
- Publication date Sep 10, 2009
- David Anthony Barda
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PURINE DERIVATIVES AS KINASE INHIBITORS
- Publication number 20090105229
- Publication date Apr 23, 2009
- Thomas Albert Engler
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Purine derivatives as kinase inhibitors
- Publication number 20050090483
- Publication date Apr 28, 2005
- Eli Lilly and Company
- Thomas Albert Engler
- C07 - ORGANIC CHEMISTRY

Joshua Ryan Clayton

Person

Patents Grantslast 30 patents

Glucocorticoid receptor agonists

Pyrazolylaminobenzimidazole derivatives as JAK inhibitors

Pyrazolylaminobenzimidazole derivatives as JAK inhibitors

JAK1 inhibitors

Inhibitor of JAK1 and JAK2

AKT inhibitors

Purine derivatives as kinase inhibitors

Amino pyrazole compound

Imidazo[1,2-A]pyridine compounds as VEGF-R2 inhibitors

Pyrrole-2, 5dione derivatives and their used as GSK-3 inhibitors

Patents Applicationslast 30 patents

HUMAN INTERLEUKIN-4 RECEPTOR ALPHA ANTIBODY GLUCOCORTICOID CONJUGATES

HUMAN TUMOR NECROSIS FACTOR ALPHA ANTIBODY GLUCOCORTICOID CONJUGATES

GLUCOCORTICOID RECEPTOR AGONISTS

GLUCOCORTICOID RECEPTOR AGONISTS

PYRAZOLYLAMINOBENZIMIDAZOLE DERIVATIVES AS JAK INHIBITORS

PYRAZOLYLAMINOBENZIMIDAZOLE DERIVATIVES AS JAK INHIBITORS

JAK1 Inhibitors

INHIBITOR OF JAK1 AND JAK2

AKT INHIBITORS

PURINE DERIVATIVES AS KINASE INHIBITORS

PURINE DERIVATIVES AS KINASE INHIBITORS

AMINO PYRAZOLE COMPOUND

AMINO PYRAZOLE COMPOUND

IMIDAZO[1,2-A]PYRIDINE COMPOUNDS AS VEGF-R2 INHIBITORS

PURINE DERIVATIVES AS KINASE INHIBITORS

Purine derivatives as kinase inhibitors